4-[4-(2-pyridin-2-ylethoxy)-6-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)-2-pyridinyl]morpholine
C29H32N4O2 — CID 58060121
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-(2-pyridin-2-ylethoxy)-6-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)-2-pyridinyl]morpholine
4-[4-(2-pyridin-2-ylethoxy)-6-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)-2-pyridinyl]morpholine (PubChem CID 58060121) has the molecular formula C29H32N4O2 and a molecular weight of 468.60 g/mol. Its IUPAC name is 4-[4-(2-pyridin-2-ylethoxy)-6-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)-2-pyridinyl]morpholine.
Molecular Properties
| Compound Name | 4-[4-(2-pyridin-2-ylethoxy)-6-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)-2-pyridinyl]morpholine |
|---|---|
| PubChem CID | 58060121 |
| Molecular Formula | C29H32N4O2 |
| Molecular Weight | 468.60 g/mol |
| Exact Mass | 468.25 |
| IUPAC Name | 4-[4-(2-pyridin-2-ylethoxy)-6-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)-2-pyridinyl]morpholine |
| SMILES | c1ccc(CCOc2cc(Cc3ccc4[nH]c5c(c4c3)CCCC5)nc(N3CCOCC3)c2)nc1 |
| InChI | InChI=1S/C29H32N4O2/c1-2-7-27-25(6-1)26-18-21(8-9-28(26)32-27)17-23-19-24(35-14-10-22-5-3-4-11-30-22)20-29(31-23)33-12-15-34-16-13-33/h3-5,8-9,11,18-20,32H,1-2,6-7,10,12-17H2 |
| InChIKey | WIQOLDAOVPOASR-UHFFFAOYSA-N |
| XLogP | 4.89 |
| TPSA | 63.27 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.60 |
| LogP ≤ 5 | 4.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58060121 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.